We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
OSCR icon
1
Oscar Health
OSCR
$10B
$10B $32.14 4.86%
HNGE icon
2
Hinge Health
HNGE
$9.9B
$9.9B $122.19 5.55%
HSIC icon
3
Henry Schein
HSIC
$9.8B
$9.8B $88.41 2.74%
TGTX icon
4
TG Therapeutics
TGTX
$9.7B
$9.7B $63.38 5.93%
PRAX icon
5
Praxis Precision Medicines
PRAX
$9.3B
$9.3B $332.97 19.9%
ATR icon
6
AptarGroup
ATR
$9.14B
$9.14B $144.13 1.14%
KRYS icon
7
Krystal Biotech
KRYS
$8.98B
$8.98B $303.06 0.72%
TWST icon
8
Twist Bioscience
TWST
$8.97B
$8.97B $135.34 12%
PTGX icon
9
Protagonist Therapeutics
PTGX
$8.79B
$8.79B $135.90 2.92%
TXG icon
10
10x Genomics
TXG
$8.48B
$8.48B $65.05 9.73%
HQY icon
11
HealthEquity
HQY
$8.45B
$8.45B $102.11 1.47%
CORT icon
12
Corcept Therapeutics
CORT
$8.11B
$8.11B $75.03 3.11%
RYTM icon
13
Rhythm Pharmaceuticals
RYTM
$7.9B
$7.9B $113.94 1.48%
KNSA icon
14
Kiniksa Pharmaceuticals
KNSA
$7.76B
$7.76B $98.76 5.22%
ALKS icon
15
Alkermes
ALKS
$7.76B
$7.76B $46.17 0.59%
PACS icon
16
PACS Group
PACS
$7.74B
$7.74B $48.77 1.67%
CYTK icon
17
Cytokinetics
CYTK
$7.68B
$7.68B $55.14 2.7%
ABVX icon
18
Abivax
ABVX
$7.62B
$7.62B $87 1.48%
IBRX icon
19
ImmunityBio
IBRX
$7.54B
$7.54B $7.11 17.7%
BLCO icon
20
Bausch + Lomb
BLCO
$7.49B
$7.49B $20.96 4.85%
AMRX icon
21
Amneal Pharmaceuticals
AMRX
$7.41B
$7.41B $21.28 5.66%
CAI icon
22
Caris Life Sciences
CAI
$7.33B
$7.33B $25.57 1.35%
IMVT icon
23
Immunovant
IMVT
$7.26B
$7.26B $35.15 15.1%
AXSM icon
24
Axsome Therapeutics
AXSM
$7.05B
$7.05B $133.96 1.2%
CHE icon
25
Chemed
CHE
$6.97B
$6.97B $538.06 1.9%

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 150 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $687B.

The largest by market cap are Oscar Health (OSCR) at $10B, Hinge Health (HNGE) at $9.9B and Henry Schein (HSIC) at $9.8B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 150 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.